Nasobronchial interaction mechanisms in allergic airways disease

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 14, Issue 3, 2006, Pages 176-182

  Braunstahl, Gert Jan ^a   Hellings, Peter W ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Allergic rhinitis; Asthma; Immunopathology; Interaction mechanisms; Treatment

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BECLOMETASONE; BRONCHODILATING AGENT; CORTICOSTEROID; DESLORATADINE; FLUTICASONE PROPIONATE; IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; OMALIZUMAB; STAPHYLOCOCCUS ENTEROTOXIN; TOXIC SUBSTANCE;

AIRWAY; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ATOPY; BACTERIAL INFECTION; BLOOD; BONE MARROW; BREATHING; BRONCHUS; BRONCHUS HYPERREACTIVITY; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; COMORBIDITY; DISEASE COURSE; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; FUME; GENE EXPRESSION; HUMAN; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INCIDENCE; LOWER RESPIRATORY TRACT; LUNG ASPIRATION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; NOSE; OCCUPATIONAL EXPOSURE; PERCEPTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOGNITION; REVIEW; RHINOCONJUNCTIVITIS; RISK ASSESSMENT; SENSITIZATION; SMOKING; STIMULATION; SYMPTOM; SYSTEMIC CIRCULATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUBERCULOSIS; UPPER RESPIRATORY TRACT; VIRAL RESPIRATORY TRACT INFECTION;

ASTHMA; BRONCHI; HUMANS; NOSE; RESPIRATORY HYPERSENSITIVITY; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 33744952562     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000193186.15440.39     Document Type: Review

References (72)

1. Blackley CH. In: Experimental researches of the causes and nature of catarrhus aestivus (hay-fever and hay-asthma). London: Baillière Tindall & Cox; 1873.
2. Welsh PW, Stricker WE, Chu CP, et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987; 62:125-134.
3. Taramarcaz P, Gibson PG. The effectiveness of intranasal corticosteroids in combined allergic rhinitis and asthma syndrome. Clin Exp Allergy 2004; 34:1883-1889.
4. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S147-S334.
5. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351:1225-1232.
6. Law M, Morris JK, Wald N, et al. Changes in atopy over a quarter of a century, based on cross sectional data at three time periods. BMJ 2005; 330:1187-1188 (Epub 15 April 2005).
7. Janson C, Anto J, Burney P, et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001; 18:598-611.
8. Braunstahl GJ, Fokkens WJ, Overbeek SE, et al. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. Clin Exp Allergy 2003; 33:579-587.
9. Chakir J, Laviolette M, Turcotte H, et al. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol 2000; 106:904-910.
10. Leynaert B, Neukirch C, Kony S, et al. Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol 2004; 113:86-93.
11. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002; 109:419-425.
12. Nguyen LH, Manoukian JJ, Sobol SE, et al. Similar allergic inflammation in the middle ear and the upper airway: evidence linking otitis media with effusion to the united airways concept. J Allergy Clin Immunol 2004; 114:1110-1115. The first study to investigate the inflammatory profiles in the ear and airways simultaneously in a group of atopic and nonatopic children undergoing myringotomy, tympanostomy tube replacement and adenoidectomy.
13. Deal RT, Kountakis SE. Significance of nasal polyps in chronic rhinosinusitis: symptoms and surgical outcomes. Laryngoscope 2004; 114:1932-1935.
14. Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps: executive summary. Allergy 2005; 60:583-601. A state-of-the-art document providing a clear, evidence-based overview of the diagnosis, treatment and management of rhinosinusitis and nasal polyposis.
15. ten Brinke A, Grootendorst DC, Schmidt JT, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 2002; 109:621-626.
16. Barnes KC. Genetics and epidemiology. Curr Opin Allergy Clin Immunol 2002; 2:375-378.
17. Aberg N, Sundell J, Eriksson B, et al. Prevalence of allergic diseases in schoolchildren in relation to family history, upper respiratory infections, and residential characteristics. Allergy 1996; 51:232-237.
18. Bjorksten B. The environmental influence on childhood asthma. Allergy 1999; 54:17-23.
19. Leynaert B, Neukirch C, Jarvis D, et al. Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am J Respir Crit Care Med 2001; 164:1829-1834.
20. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001; 358:1129-1133.
21. Ehrlich RI, White N, Norman R, et al. Wheeze, asthma diagnosis and medication use: a national adult survey in a developing country. Thorax 2005; 60:895-901. A South African survey describing several risk factors involved in asthma that are unique to a developing country, such as tuberculosis and mining.
22. Annesi-Maesano I, Oryszczyn MP, Raherison C, et al. Increased prevalence of asthma and allied diseases among active adolescent tobacco smokers after controlling for passive smoking exposure. A cause for concern? Clin Exp Allergy 2004; 34:1017-1023. An epidemiological multicenter survey among adolescents investigating the effect of active smoking on the prevalence of asthma and atopic diseases.
23. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991; 266:225-230.
24. Schmidt SM, Muller CE, Wiersbitzky SK. Inverse association between Chlamydia pneumoniae respiratory tract infection and initiation of asthma or allergic rhinitis in children. Pediatr Allergy Immunol 2005; 16:137-144. A well designed prospective cohort study comprising 1211 children who were followed up for 2 years after acute or persistent C. pneumoniae respiratory tract infection. The aim of the study was to record the initiation rate of allergic diseases.
25. Resch A, Schlipkoter U, Crispin A, et al. Atopic disease and its determinants - a focus on the potential role of childhood infection. Clin Exp Allergy 2004; 34:1184-1191.
26. Van Zele T, Gevaert P, Watelet JB, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004; 114:981-983.
27. Alho OP, Karttunen R, Karttunen TJ. Nasal mucosa in natural colds: effects of allergic rhinitis and susceptibility to recurrent sinusitis. Clin Exp Immunol 2004; 137:366-372.
28. Polosa R, Ciamarra I, Mangano G, et al. Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J 2000; 15:30-35.
29. Aronsson D, Tufvesson E, Bjermer L. Allergic rhinitis with or without concomitant asthma: difference in perception of dyspnoea and levels of fractional exhaled nitric oxide. Clin Exp Allergy 2005; 35:1457-1461. A well designed prospective cohort study comprising 1211 children who were followed up for 2 years after acute or persistent C. pneumoniae respiratory tract infection. The aim of the study was to record the initiation rate of allergic diseases.
30. Bousquet J, Boushey HA, Busse WW, et al. Characteristics of patients with seasonal allergic rhinitis and concomitant asthma. Clin Exp Allergy 2004; 34:897-903.
31. Leynaert B, Neukirch C, Liard R, et al. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000; 162:1391-1396.
32. Bochner BS, Busse WW. Allergy and asthma. J Allergy Clin Immunol 2005; 115:953-959.
33. McLane ML, Nelson JA, Lenner KA, et al. Integrated response of the upper and lower respiratory tract of asthmatic subjects to frigid air. J Appl Physiol 2000; 88:1043-1050.
34. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992; 89:611-618.
35. Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001; 107:469-476.
36. Ciprandi G, Cirillo I, Vizzaccaro A, et al. Airway function and nasal inflammation in seasonal allergic rhinitis and asthma. Clin Exp Allergy 2004; 34:891-896.
37. Ciprandi G, Vizzaccaro A, Cirillo I, et al. Nasal eosinophils display the best correlation with symptoms, pulmonary function and inflammation in allergic rhinitis. Int Arch Allergy Immunol 2005; 136:266-272 (Epub 17 February 2005). A similar study in allergic rhinitis patients with various levels of BHR, investigating the association between upper airway inflammation and lower airway function.
38. Ozcan M, Ortapamuk H, Naldoken S, et al. Pulmonary aspiration of nasal secretions in patients with chronic sinusitis and asthma. Arch Otolaryngol Head Neck Surg 2003; 129:1006-1009.
39. Bardin PG, Van Heerden BB, Joubert JR. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. J Allergy Clin Immunol 1990; 86:82-88.
40. Dinh QT, Mingomataj E, Quarcoo D, et al. Allergic airway inflammation induces tachykinin peptides expression in vagal sensory neurons innervating mouse airways. Clin Exp Allergy 2005; 35:820-825.
41. Rosenberg GL, Rosenthal RR, Norman PS. Inhalation challenge with rag-weed pollen in ragweed-sensitive asthmatics. J Allergy Clin Immunol 1983; 71:302-310.
42. Dunlop G, Scadding GK, Lund VJ. The effect of endoscopic sinus surgery on asthma: management of patients with chronic rhinosinusitis, nasal polyposis, and asthma. Am J Rhinol 1999; 13:261-265.
43. Griffin MP, McFadden ER Jr. Ingram RH Jr. Airway cooling in asthmatic and nonasthmatic subjects during nasal and oral breathing. J Allergy Clin Immunol 1982; 69:354-359.
44. Assanasen P, Baroody FM, Abbott DJ, et al. Natural and induced allergic responses increase the ability of the nose to warm and humidify air. J Allergy Clin Immunol 2000; 106:1045-1052.
45. Assanasen P, Baroody FM, Naureckas E, et al. The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air. Am J Respir Crit Care Med 2001; 164:1640-1646.
46. Hellings PW, Hessel EM, Van Den Cord JJ, et al. Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyper-reactivity in sensitized mice exposed to aerosolized allergen. Clin Exp Allergy 2001; 31:782-790.
47. Beeh KM, Beier J, Kornmann O, et al. A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy 2003; 33:475-482.
48. Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001; 164:858-865.
49. Denburg JA, Inman MD, Sehmi R, et al. Hemopoietic mechanisms in allergic airway inflammation. Int Arch Allergy Immunol 1998; 117:155-159.
50. Braunstahl GJ. The unified immune system: respiratory tract-nasobronchial interaction mechanisms in allergic airway disease. J Allergy Clin Immunol 2005; 115:142-148.
51. Custovic A, Simpson BM, Simpson A, et al. Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial. Lancet 2001; 358:188-193.
52. Terreehorst I, Hak E, Oosting AJ, et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med 2003; 349:237-246.
53. Woodcock A, Forster L, Matthews E, et al. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med 2003; 349:225-236.
54. Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109:57-62.
55. Corren J, Manning BE, Thompson SF, et al. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol 2004; 113:415-419. A case-control study based on insurance claim data of a cohort of patients identified with asthma and allergy. The effect of rhinitis treatment (e.g. nasal corticosteroids and second-generation antihistamines) on asthma exacerbations was studied.
56. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992; 90:250-256.
57. Aubier M, Levy J, Clerici C, et al. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992; 146:122-126.
58. Stelmach R, Nunes M, Ribeiro M, Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest 2005; 128:3140-3147. A double-blind parallel study of sufficient size looking at the efficacy of intranasal beclomethasone treatment with respect to asthma control. The follow-up was much longer than in other studies with a comparable design.
59. Dahl R, Nielsen LP, Kips J, et al. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy 2005; 60:875-881. A large randomized, double-blind, double-dummy, placebo-controlled, parallel-group, multicenter study comparing intranasal and inhaled fluticasone propionate with regard to asthma control in patients with allergic rhinitis and asthma.
60. Nathan RA, Yancey SW, Waitkus-Edwards K, et al. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest 2005; 128:1910-1920. A 4-week, randomized, double-blind, parallel-group study comparing intranasal and montelukast in patients with allergic rhinitis and asthma with regard to asthma symptoms and lung function.
61. Roberts G, Hurley C, Bush A, Lack G. Longitudinal study of grass pollen exposure, symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma. Thorax 2004; 59:752-756.
62. Gibson PG, Saltos N, Borgas T. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma. J Allergy Clin Immunol 2000; 105:752-759.
63. Busse W, Kraft M. Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 2005; 127:1312-1326. An interesting and readable review about the role of cysteinyl leukotrienes and their modifiers in allergic airway disease.
64. Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004; 20:1549-1558.
65. Pullerits T, Praks L, Skoogh BE, et al. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Crit Care Med 1999; 159:1814-1818.
66. Reinartz SM, Overbeek SE, Kleinjan A, et al. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients. Allergy 2005; 60:1301-1307. A parallel-group, double-blind, placebo-controlled trial investigating the systemic and lower airway protective effect of desloratidine in asthmatic patients with rhinitis using an allergen challenge model.
67. Baena-Cagnani CE, Berger WE, DuBuske LM, et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003; 130:307-313.
68. Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109:251-256.
69. Polosa R, Li Gotti F, Mangano G, et al. Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis. Allergy 2004; 59:1224-1228. A parallel-group, double-blind, placebo-controlled trial of 3-year duration during which the clinical effects of SIT were investigated in a group of rhinitis patients allergic to Parietaria.
70. Marogna M, Spadolini I, Massolo A, et al. Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol 2005; 115:1184-1188.
71. Rak S, Heinrich C, Jacobsen L, et al. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol 2001; 108:921-928.
72. Holgate ST, Djukanovic R, Casale T, Bousquet J. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy 2005; 35:408-416. A very good overview of the current literature discussing the anti-inflammatory aspects of anti-IgE treatment as well as its clinical efficacy.